Peripheral exudative hemorrhagic chorioretinopathy (PEHCR) is a rare condition characterized by retinal and choroidal changes observed in the periphery of the fundus. Most cases are asymptomatic. Due to the dark color and prominence of the retina in the periphery, this disease is often mistaken for choroidal melanoma. Material and methods. This article presents a clinical case report of a patient, a 77-yearold female, presented with sudden vision deterioration in her left eye and was diagnosed with PEHCR. Standard ophthalmic examinations including visual acuity, tonometry, ophthalmoscopy, spectral optical coherence tomography, ultrasonography, color Doppler imaging, and fluorescein angiography were performed. Following diagnosis, the patient received intravitreal injections of brolucizumab for treatment. Results. Significant improvement was observed in the patient's condition following antiVEGF therapy, with reduced retinal thickness and intraretinal cystic cavities in the macular region, as well as decreased neovascular membrane activity. Repeat injections further improved the patient's visual acuity and reduced peripheral retinal changes. Conclusion. PEHCR is a rare disease of the peripheral retina and choroid, which is often asymptomatic but can mimic serious life-threatening diseases, so it is important to correctly diagnose this disease using a multimodal approach to avoid misdiagnosis and determine treatment strategies. Keywords: peripheral exudative hemorrhagic chorioretinopathy, pseudomelanoma, аntivascular endothelial growth factor